Growth Metrics

Novartis Ag (NVS) Short-term Investments (2016 - 2025)

Novartis Ag's Short-term Investments history spans 12 years, with the latest figure at $98.0 million for Q4 2025.

  • On a quarterly basis, Short-term Investments fell 95.1% to $98.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $98.0 million, a 95.1% decrease, with the full-year FY2025 number at $98.0 million, down 95.1% from a year prior.
  • Short-term Investments hit $98.0 million in Q4 2025 for Novartis Ag, down from $2.0 billion in the prior quarter.
  • Over the last five years, Short-term Investments for NVS hit a ceiling of $15.9 billion in Q4 2021 and a floor of $98.0 million in Q4 2025.
  • Historically, Short-term Investments has averaged $6.1 billion across 5 years, with a median of $2.0 billion in 2024.
  • Biggest five-year swings in Short-term Investments: skyrocketed 735.8% in 2021 and later crashed 95.1% in 2025.
  • Tracing NVS's Short-term Investments over 5 years: stood at $15.9 billion in 2021, then decreased by 28.32% to $11.4 billion in 2022, then crashed by 90.93% to $1.0 billion in 2023, then soared by 93.04% to $2.0 billion in 2024, then crashed by 95.1% to $98.0 million in 2025.
  • Business Quant data shows Short-term Investments for NVS at $98.0 million in Q4 2025, $2.0 billion in Q4 2024, and $1.0 billion in Q4 2023.